Coloplast is a global manufacturer of intimate healthcare products and a market leader in ostomy, continence care, and voice and respiratory care, while holding smaller positions in wound care and interventional urology.
Coloplast's dominant position in ostomy and continence care is built on decades of innovation and customer relationships that are difficult to replicate and supports both pricing resilience and long-term customer retention.
With the majority of revenue subject to third-party reimbursement, Coloplast is structurally exposed to healthcare cost containment—most concretely illustrated by the anticipated introduction of Medicare competitive bidding in the US from 2028 onward.
|
Metric
|
COLO B
|
CTEC
|
SNN
|
|---|---|---|---|
Price/Earnings (Normalized) | 35.05 | 23.76 | 14.39 |
Price/Book Value | 7.68 | 4.18 | 2.27 |
Price/Sales | 3.61 | 2.47 | 1.91 |
Price/Cash Flow | 13.10 | 13.35 | 9.79 |
|
Metric
|
COLO B
|
CTEC
|
SNN
|
|---|---|---|---|
Quick Ratio | 0.88 | 1.06 | 1.11 |
Current Ratio | 1.56 | 1.93 | 2.14 |
Interest Coverage | 6.65 | 3.34 | 5.42 |
|
Metric
|
COLO B
|
CTEC
|
SNN
|
|---|---|---|---|
Return on Assets (Normalized) | 11.86% | 9.54% | 8.51% |
Return on Equity (Normalized) | 38.99% | 22.72% | 17.09% |
Return on Invested Capital (Normalized) | 15.76% | 13.15% | 11.66% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|tDl>#gZ> | LOCK|pQ | $151B | |||
| Becton Dickinson & Co
BDX
| LOCK|db | LOCK|lrk^v | $53B | |||
| ResMed Inc
RMD
| LOCK|P!CcC^P | LOCK|#L>p | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|@w!Htsk | LOCK|yYL# | $32B | |||
| Alcon Inc
ALC
| LOCK|@QS&Zg | LOCK|v&g@ | $32B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|>wmqP^x | LOCK|&Br | $27B | |||
| Solventum Corp
SOLV
| LOCK|Z!>kl& | LOCK|Cy% | $15B | |||
| Baxter International Inc
BAX
| LOCK|pv& | LOCK|$&>& | $13B | |||
| Repligen Corp
RGEN
| LOCK|t>$sybRw | LOCK|$%!> | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|%@>Brj | LOCK|yxGj | $11B |
United States